Clinical Trial

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Name: Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — clinical trial record (NCT07064759)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: 4FRONT-2

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Protocol Amendment History 1 change

notable Trial sites expanded: 43 -> 94 locations 2026-04-17

Trial Details

NCT Number	NCT07064759
Lead Sponsor	4D Molecular Therapeutics
Conditions	Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment	480 participants
Start Date	2025-07-22
Primary Completion	2028-11 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-16